- Investing Ideas
- Swedish Pharmaceuticals & Biotech Low-Risk Leaders
Swedish Pharmaceuticals & Biotech Low-Risk Leaders
Results
2
0 new
Every great portfolio needs a good foundation. Our selection of stocks can help you lower your risk without sacrificing your returns. Invest in the market's most resilient companies with strong balance sheets and the lowest risk scores in our model.
2 companies
Camurus
Market Cap: SEK 32.4b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 542.00
7D
5.8%
1Y
-12.7%
Bonesupport Holding
Market Cap: SEK 15.2b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 230.80
7D
7.6%
1Y
-12.8%